Medicaid
The Centers for Medicare…
North Carolina Dec. 1 expanded Medicaid to low-income adults under the Affordable Care Act and state legislation enacted in March.
The AHA and seven other national organizations representing hospitals Nov. 29 voiced strong support for a Medicaid managed care proposal to establish the Average Commercial Rate as the upper payment limit for inpatient and outpatient hospital services in the context of state directed payments, but…
We strongly support CMS’ efforts to ensure that providers have the resources they need to care for Medicaid beneficiaries, including by increasing transparency and oversight in provider payment. However, we are deeply concerned that certain proposed policies may undercut the agency’s efforts by…
While the Medicaid renewal process can be easy and seamless for some individuals, for others the process may be complicated and result in confusion and termination of coverage, the Kaiser Family Foundation reports based on focus groups it conducted with enrollees in three states.
As millions of people are losing their Medicaid coverage as a result of the redetermination process, hospitals and health systems are seeing substantial increases in uncompensated care and facing new Medicare cuts that will exacerbate their financial challenges, according to a AHA blog post …
The Medicaid program now faces the most significant coverage challenge in more than a decade. Consequently, over the past few months, hospitals have started to see a substantial increase in uncompensated care.
The Centers for Medicare the Centers for Medicare & Medicaid Services Sept. 18 finalized select provisions in its proposed rule to streamline Medicaid and Children’s Health Insurance Program enrollment.
The Health and Human Services Office of Inspector General Aug. 28 released a strategic plan to align its audits, evaluations, investigations and enforcement of managed care plans in Medicare Advantage and Medicaid.
The Department of Health and Human Services announced the first list of Medicare Part D drugs subject to price negotiations, a tenet of the Inflation Reduction Act designed to reduce health care costs.